全文获取类型
收费全文 | 142139篇 |
免费 | 10838篇 |
国内免费 | 4118篇 |
专业分类
耳鼻咽喉 | 1095篇 |
儿科学 | 2754篇 |
妇产科学 | 1957篇 |
基础医学 | 8884篇 |
口腔科学 | 3123篇 |
临床医学 | 17178篇 |
内科学 | 21352篇 |
皮肤病学 | 2513篇 |
神经病学 | 7391篇 |
特种医学 | 5213篇 |
外国民族医学 | 40篇 |
外科学 | 14046篇 |
综合类 | 20404篇 |
现状与发展 | 27篇 |
一般理论 | 2篇 |
预防医学 | 6102篇 |
眼科学 | 2310篇 |
药学 | 13036篇 |
77篇 | |
中国医学 | 11679篇 |
肿瘤学 | 17912篇 |
出版年
2024年 | 268篇 |
2023年 | 2348篇 |
2022年 | 4438篇 |
2021年 | 6070篇 |
2020年 | 5599篇 |
2019年 | 5048篇 |
2018年 | 4864篇 |
2017年 | 5302篇 |
2016年 | 5658篇 |
2015年 | 5474篇 |
2014年 | 10066篇 |
2013年 | 12601篇 |
2012年 | 8415篇 |
2011年 | 9068篇 |
2010年 | 7433篇 |
2009年 | 6855篇 |
2008年 | 6791篇 |
2007年 | 7091篇 |
2006年 | 6293篇 |
2005年 | 5644篇 |
2004年 | 4568篇 |
2003年 | 4164篇 |
2002年 | 3432篇 |
2001年 | 2939篇 |
2000年 | 2485篇 |
1999年 | 1969篇 |
1998年 | 1667篇 |
1997年 | 1426篇 |
1996年 | 1219篇 |
1995年 | 1131篇 |
1994年 | 891篇 |
1993年 | 717篇 |
1992年 | 617篇 |
1991年 | 584篇 |
1990年 | 468篇 |
1989年 | 412篇 |
1988年 | 420篇 |
1987年 | 341篇 |
1986年 | 292篇 |
1985年 | 340篇 |
1984年 | 311篇 |
1983年 | 220篇 |
1982年 | 221篇 |
1981年 | 221篇 |
1980年 | 179篇 |
1979年 | 164篇 |
1978年 | 98篇 |
1977年 | 65篇 |
1976年 | 62篇 |
1975年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
Tasuku Ogita Rosaly Vallejo Manaois Manabu Wakagi Tomoyuki Oki Yuko Takano Ishikawa 《International journal of food sciences and nutrition》2016,67(4):431-440
Two cultivars of Japanese parsley were harvested in different seasons; their antioxidant capacities were evaluated by oxygen radical absorbance capacity (ORAC) methods, and the contents of hydrophilic and lipophilic antioxidants were compared. Japanese parsley possessed potent antioxidant capacities both in hydrophilic and lipophilic extracts when evaluated by ORAC methods. LC/MS/MS analyses revealed that chlorogenic acid and four kinds of quercetin glycosides were major antioxidants in the hydrophilic extract. Lutein was the main contributor to the antioxidant capacity of the lipophilic extract. Antioxidant capacities of the hydrophilic extracts of both cultivars tended to be higher in winter because of the increase in the contents of chlorogenic acid and quercetin glycosides. An obvious trend in the lipophilic antioxidant capacities or lutein contents was not observed irrespective of the cultivar. 相似文献
74.
75.
中西医结合治疗动眼神经麻痹疗效观察 总被引:2,自引:0,他引:2
李春林 《中国实用神经疾病杂志》2015,(10)
目的了解中西医结合法治疗动眼神经麻痹的临床疗效。方法对我院2012-03—2014-03收治的动眼神经麻痹患者进行抽样,择取74例患者随机分成2组,对照组予以基础性西医疗法,实验组在对照组治疗基础上予以中医疗法(包括针刺及服用中药正容汤等),观察2组患者的临床治疗效果。结果实验组总有效率(94.60%)明显高于对照组(64.86%),差异具有统计学意义(P0.05)。结论中西医结合法治疗动眼神经麻痹临床疗效确切,安全系数高,值得临床大力推广使用。 相似文献
76.
《Urologic oncology》2015,33(5):217-225
Although both surgery and radiation are potential curative options for men with clinically localized prostate cancer, a significant proportion of men with high-risk and locally advanced disease will demonstrate biochemical and potentially clinical progression of their disease. Neoadjuvant systemic therapy before radical prostatectomy (RP) is a logical strategy to improve treatment outcomes for men with clinically localized high-risk prostate cancer. Furthermore, delivery of chemotherapy and other systemic agents before RP affords an opportunity to explore the efficacy of these agents with pathologic end points.Neoadjuvant chemotherapy, primarily with docetaxel (with or without androgen deprivation therapy), has demonstrated feasibility and safety in men undergoing RP, but no study to date has established the efficacy of neoadjuvant chemotherapy or neoadjuvant chemohormonal therapies. Other novel agents, such as those targeting the vascular endothelial growth factor receptor, epidermal growth factor receptor, platelet-derived growth factor receptor, clusterin, and immunomodulatory therapeutics, are currently under investigation. 相似文献
77.
78.
79.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
80.